IGF1 and Parkinson disease: Additionally, but to a lesser extent, there is a third objective: to cover articles that have measured IGF peripheral members and depressive symptoms without a proper MDD diagnosis, such as in population-based studies or in concomitant diseases including fibromyalgia or Parkinson’s disease.